• 1
    Grana, X., De Luca, A., Sang, N., Fu, Y., Claudio, P.P., Rosenblatt, J., Morgan, D.O. & Giordano, A. (1994) PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. Proc. Natl Acad. Sci. USA 91, 38343838.
  • 2
    Fisher, P.M. & Gianella-Borradori, A. (2003) CDK inhibitors in clinical development for the treatment of cancer. Expert Opin. Investig. Drugs 12, 955970.
  • 3
    MacLachlan, T.K., Sang, N. & Giordano, A. (1995) Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit. Rev. Eukaryot. Gene Expr. 5, 127156.
  • 4
    Edwards, M.C., Wong, C. & Elledge, S.J. (1998) Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Mol. Cell. Biol. 18, 42914300.
  • 5
    Coqueret, O. (2002) Linking cyclins to transcriptional control. Gene 299, 3555.
  • 6
    Jackman, M.R. & Pines, J.N. (1997) Cyclins an the G2/M transition. Cancer Surv. 29, 4773.
  • 7
    Shuttleworth, J. (1995) The regulation and functions of cdk7. Prog. Cell Cycle Res. 1, 229240.
  • 8
    Tang, D. & Wang, J.H. (1996) Cyclin-dependent kinase 5 (Cdk5) and neuron-specific Cdk5 activators. Prog. Cell Cycle Res. 2, 205216.
  • 9
    Lee, W.H., Bookstein, R., Hong, F., Young, L.J., Shew, J.Y. & Lee, E.Y. (1987) Human retinoblastoma susceptibility gene: cloning, idengification, and sequence. Science 235, 13941399.
  • 10
    Tassan, J.P., Schultz, S.J., Bartek, J. & Nigg, E.A. (1994) Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell. Biol. 127, 467478.
  • 11
    Kaldis, P., Russo, A.A., Chou, H.S., Pavletich, N.P. & Solomon, M.J. (1998) Human and yeast Cdk-activatin kinases (CAKs) display distinct substrate specificities. Mol. Biol. Cell 9, 25452560.
  • 12
    Chen, P.-L., Scully, P., Shew, J.-Y., Wang, J.Y.J. & Lee, W.-H. (1989) Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58, 11931198.
  • 13
    DeCaprio, J.A., Ludlow, J.W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica-Worms, H., Huang, C.-M. & Livingston, D.M. (1989) The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 10851095.
  • 14
    Chellappan, S.P., Hiebert, S., Mudryj, M., Horowitz, J.M. & Nevins, J.R. (1991) The E2F transcription factor is a cellular target for the Rb protein. Cell 65, 10531061.
  • 15
    Weintraub, S.J., Prater, C.A. & Dean, D.C. (1992) Retinoblastoma protein switches the E2F site from positive to negative element. Nature 358, 259261.
  • 16
    Hiebert, S.W. (1993) Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol. Cell. Biol. 13, 33843391.
  • 17
    Blake, M.C. & Azizkhan, J.C. (1989) Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 49945002.
  • 18
    Slansky, J.E. & Farnham, P.J. (1996) Transcriptional regulation of the dihydrofolate reductase gene. Bioassays 18, 5562.
  • 19
    Pearson, B.E., Nasheuer, H.P. & Wang, T.S. (1991) Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum stimulated cells. Mol. Cell. Biol. 11, 20812095.
  • 20
    Dou, Q.P., Fridovich Keil, J.L. & Pardee, A.B. (1991) Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase. Proc. Natl Acad. Sci. USA 88, 11571161.
  • 21
    Dou, Q.P., Zhao, S., Levin, A.H., Wang, J., Helin, K. & Pardee, A.B. (1994) G1/S regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. J. Biol. Chem. 269, 13061313.
  • 22
    Oswald, F., Dobner, T. & Lipp, M. (1996) The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle. Mol. Cell. Biol. 16, 18891895.
  • 23
    Lee, H.H., Chiang, W.H., Chiang, S.H., Liu, Y.C., Hwang, J. & Ng, S.Y. (1995) Regulation of cyclin D1, DNA topoisomerase I, and proliferating cell nuclear antigen promoters during the cell cycle. Gene Expr. 4, 95109.
  • 24
    Lam, E.W., Morris, J.D., Davies, R., Crook, T., Watson, R.J. & Vousden, K.H. (1994) HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes. EMBO J. 13, 871878.
  • 25
    Zwicker, J., Liu, N., Engeland, K., Lucibello, F.C. & Müller, R. (1996) Cell cycle regulation of E2F site occupation in vivo. Science 271, 15951597.
  • 26
    Herber, B., Truss, M., Beato, M. & Müller, R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene 9, 12951304.
  • 27
    Müller, H., Lukas, J., Schneider, A., Warthoe, P., Bartek, J., Eilers, M. & Strauss, M. (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc. Natl Acad. Sci. USA 91, 29452949.
  • 28
    Botz, J., Zerfass Thome, K., Spitkovsky, D., Delius, H., Vogt, B., Eilers, M., Hatzigeorgiou, A. & Jansen Durr, P. (1996) Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16, 34013409.
  • 29
    Henglein, B., Chenivesse, X., Wang, J., Eick, D. & Brechot, C. (1994) Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc. Natl Acad. Sci. USA 91, 54905494.
  • 30
    Schulze, A., Zerfass, K., Spitkovsky, D., Middendorp, S., Berges, J., Helin, K., Jansen Durr, P. & Henglein, B. (1995) Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl Acad. Sci. USA 92, 1126411268.
  • 31
    Dalton, S. (1992) Cell cycle regulation of the human cdc2 gene. EMBO J. 11, 17971804.
  • 32
    Furukawa, Y., Terui, Y., Sakoe, K., Ohta, M. & Saito, M. (1994) The role of cellular transcription factor E2F in the regulation of cdc2 mRNA expression and cell cycle control of human hematopoietic cells. J. Biol. Chem. 269, 2624926258.
  • 33
    Sherr, C.J. & Roberts, J.M. (1990) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 15011512.
  • 34
    LaBaer, J., Garrett, M.D., Stevenson, L.F., Slingerland, J.M., Sandhu, C., Chou, H.S., Fattaey, A. & Harlow, E. (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11, 847862.
  • 35
    Cheng, M., Olivier, P., Diehl, J.A., Fero, M., Roussel, M.F. & Roberts, J.M. (1999) The p21 (Cip) and p27 (Kip) CDK inhibitors are essential activators of cyclin D-dependent kinases in murine firoblasts. EMBO J. 18, 15711583.
  • 36
    Sausville, E.A., Zaharevitz, D., Gusio, R., Meijer, L., Louarn-Leost, M., Kunick, C., Schultz, R., Lahusen, T., Headlee, D. et al. (1999) Cyclin-dependent kinases: initial aproaches to exploit a novel therapeutic target. Pharmacol. Ther. 82, 285292.
  • 37
    Senderowicz, A.M. (2000) Small molecule modulators of cyclin-dependent kinases for cancer therapy. Oncogene 19, 66006606.
  • 38
    Van den Heuvel, S. & Harlow, E. (1993) Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262, 20502054.
  • 39
    Meijer, L., Borgne, A., Mulner, O., Chong, J.P., Blow, J.J., Inagaki, N., Iganaki, M., Delcros, J.G. & Moulinoux, J.P. (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243, 527536.
  • 40
    Park, D.S., Farinelli, S.E. & Greene, L.A. (1996) Inhibitors of cyclin-dependent kinases promote survival of post-mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271, 81618169.
  • 41
    Parker, B.W., Kaur, G., Nieves-Neira, W., Taimi, M., Kolhagen, G., Shimizu, T., Losiewicz, M.D., Pommier, Y., Sausville, E.A. & Senderowicz, A.M. (1998) Early induction of apoptosis in hematopoietic cell lines after exposure to flavopiridol. Blood 91, 458465.
  • 42
    Buquet-Fagot, C., Lallemand, F., Montagne, M.N. & Mester, J. (1997) Effects of olomucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines. Anticancer Drugs 8, 623631.
  • 43
    Lee, H.R., Chang, T.H., Tebalt, M.J. III, Senderowicz, A.M. & Szabo E. (1999) Induction of differentiation accompanies inhibition of cdk2 in non-small cell lung cancer cell line. Int. J. Oncol. 15, 161166.
  • 44
    Rosania, G.R., Merlie, J. Jr, Gray, N., Chang, Y.T., Shultz, P.G. & Heald R. (1999) A cyclin-dependent kinase inhibitor inducing cancer cell differentiation: biochemical idengification using Xenopus egg extracts. Proc. Natl Acad. Sci. USA 96, 47974802.
  • 45
    Liu, M., Subramanyam, Y.V. & Baskaran, N. (1999) Preparation and analysis of cDNA from a small number of hematopoietic cells. Methods Enzymol. 303, 4555.
  • 46
    Melillo, G., Sausville, E.A., Cloud, K., Lahusen, T., Varresio, L. & Senderowicz, A. (1999) Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. Cancer Res. 59, 54335437.
  • 47
    Gray, N.S., Wodicka, L., Thunnissen, A.M., Norman, T.C., Kwon, S., Espinoza, F.H., Morgan, D.O., Barnes, G., Le Clerc, S., Meijer, L. et al. (1998) Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281, 533538.
  • 48
    Singh, P., Coe, J. & Hong, W. (1995) A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 6, 562565.
  • 49
    Chen, P.L., Riley, D.J., Chen, Y. & Lee, W.H. (1996) Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10, 27942804.
  • 50
    Batsche, E., Muchardt, C., Behrens, J., Hurst, H.C. & Cremisi, C. (1998) RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell. Biol. 18, 36473658.
  • 51
    Noé, V., Alemany, C., Chasin, L.A. & Ciudad, C.J. (1998) Retinoblastoma protein associates with SP1 and activates the hamster dihydrofolate reductase promoter. Oncogene 16, 19311938.
  • 52
    Kim, S.J., Lee, H.D., Robbins, P.D., Busam, K., Sporn, M.B. & Roberts, A.B. (1991) Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene. Proc. Natl Acad. Sci. USA 88, 30523056.
  • 53
    Udvadia, A.J., Rogers, K.T., Higgins, P.D., Murata, Y., Martin, K.H., Humphrey, P.A. & Horowitz, J.M. (1993) Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression. Proc. Natl Acad. Sci. USA 90, 32653269.
  • 54
    Kim, S.J., Wagner, S., Liu, F., O'Reilly, M.A., Robbins, P.D. & Green, M.R. (1992) Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358, 331334.
  • 55
    Chen, L.I., Nishinaka, T., Kwan, K., Kitabayashi, I., Yokoyama, K., Fu, Y.H., Grunwald, S. & Chiu, R. (1994) The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14, 43804389.
  • 56
    Leggett, R.W., Armstrong, S.A., Barry, D. & Mueller, C.R. (1995) Sp1 is phosphorylated and its DNA binding activity down-regulated upon terminal differentiation of the liver. J. Biol. Chem. 27, 2587925884.
  • 57
    Viñals, F., Fandos, C., Santalucia, T., Ferre, J., Testar, X., Palacín, M. & Zorzano, A. (1997) Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J. Biol. Chem. 20, 1291312921.
  • 58
    Noé, V., Chen, C., Alemany, C., Nicolas, M., Caragol, I., Chasin, L.A. & Ciudad, C.J. (1997) Cell-growth regulation of the hamster dihydrofolate reductase gene promoter by transcription factor Sp1. Eur. J. Biochem. 249, 1320.
  • 59
    Black, A.R., Jensen, D., Lin, S.Y. & Azizkhan, J.C. (1999) Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 15, 12071215.
  • 60
    Saffer, J.D., Jackson, S.P. & Annarella, M.B. (1991) Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 4, 21892199.
  • 61
    Wang, C.H., Tsao, Y.P., Chen, H.J., Chen, H.L., Wang, H.W. & Chen, S.L. (2000) Transcriptional repression of p21 (Waf 1/Cip1/Sdi1) gene by c-jun through Sp1 site. Biochem. Biophys. Res. Commun. 2, 303310.
  • 62
    Decesse, J.T., Medjkane, S., Datto, M.B. & Cremisi, C.E. (2001) RB regulates transcription of the p21/WAF1/CIP1 gene. Oncogene 20, 962971.
  • 63
    Fojas de Borja, P., Du Collins, N.K.P., Azizkhan-Cliffork, J. & Mudryj, M. (2001) Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 20, 57375747.
  • 64
    Haidweger, E., Novy, M. & Rotheneder, H. (2001) Modulation of Sp1 activity by a Cyclin A/CDK complex. J. Mol. Biol. 306, 201212.
  • 65
    Nishinaka, T., Fu, Y.H., Chen, L.I., Yokoyama, K. & Chiu, R. (1997) A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor Sp1. Biochem. Biophys. Acta 1351, 274286.
  • 66
    Fu, Y.H., Nichinaka, T., Yokoyama, K. & Chiu, R. (1998) A retinoblastoma susceptibility gene product, RB, targeting protease is regulated through the cell cycle. FEBS Lett. 421, 8993.
  • 67
    Urlaub, G., McDowell, J. & Chasin, L.A. (1985) Use of fluorescence-activated cell sorter to isolate mutant mammalian cells deficient in an internal protein, dihydrofolate reductase. Somat. Cell Mol. Genet. 11, 7177.
  • 68
    Urlaub, G., Mitchell, P.J., Kas, E., Funanage, V.L., Myoda, T.T. & Hamlin, J.L. (1986) Effect of gamma rays at the dihydrofolate reductase locus: deletions and inversions. Somat. Cell Mol. Genet. 12, 555566.
  • 69
    Noé, V., Ciudad, C.J. & Chasin, L.A. (1999) Effect of differential polyadenylation and cell growth phase on dihydrofolate reductase mRNA stability. J. Biol. Chem. 274, 2780727814.
  • 70
    Ciudad, C.J., Morris, A.E., Jeng, C. & Chasin, L.A. (1992) Point mutational analysis of the hamster dihydrofolate reductase minimum promoter. J. Biol. Chem. 267, 36503656.
  • 71
    Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • 72
    Kraus, M.H., Popescu, N.C., Amsbaugh, S.C. & King, C.R. (1987) Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 6, 605610.
  • 73
    Wigler, M., Pellicer, A., Silverstein, S., Axel, A., Urlaub, G. & Chasin, L.A. (1979) Transformation of the aprt locus in mammalian cells. Proc. Natl Acad. Sci. USA 76, 13731376.
  • 74
    Ciudad, C.J., Urlaub, G. & Chasin, L.A. (1988) Deletion analysis of the Chinese Hamster dihydrofolate reductase gene promoter. J. Biol. Chem. 263, 1627416282.
  • 75
    Noé, V., Alemany, C., Nicolás, M. & Ciudad, C.J. (2001) Sp1 involvement in the 4β-phorbol 12-myristate 13-acetate (TPA)-mediated increase in resistance to methotrexate in Chinese hamster ovary cells. Eur. J. Biochem. 268, 31633173.
  • 76
    Meijer, L. (1996) Chemical inhibitors of cyclin-dependent kinases. Cell Biol. 6, 303307.
  • 77
    Kawakami, K., Futami, H., Takahara, J. & Yamaguchi, K. (1996) UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene product in A549 human lung cancer cell line. Biochem. Biophys. Res. Commun. 219, 778783.
  • 78
    Shimizu, E., Zhao, M.R., Nkanishi, H., Yamamoto, A., Yoshida, S., Takada, M., Ogura, T. & Sone, S. (1996) Differing effects of staurosporine and UCN-01 on RB protein phosphorylation and expression of lung cancer cell lines. Oncology 53, 494504.
  • 79
    Hamel, P.A., Gill, R.M., Phillips, R.A. & Gallie, B.L. (1992) Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Cell Biol. 12, 34313438.
  • 80
    Gill, R.M., Hamel, P.A., Jiang, Z., Zacksenhaus, E., Gallie, B.L., & Phillips, R.A. (1994) Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ. 5, 467474.
  • 81
    Park, K., Choe, J., Osifchin, N.E., Templeton, D.J., Robbins, P.D. & Kim, S.-J. (1994) The human retinoblastoma susceptibility gene promoter is positively autoregulated by its own product. J. Biol. Chem. 8, 60836088.
  • 82
    Sandig, V., Brand, K., Herwin, S., Lukas, J., Bartek, J. & Strauss, M. (1997) Adenovirally transferred p16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med. 3, 313319.
  • 83
    Plath, T., Peters, M., Detjen, K., Welzel, M., Marschall, Z., Radke, C., Wiedenmann, B. & Rosewicz, S. (2002) Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis. J. Natl Cancer Inst. 94, 12942.